Tony Eglezos
Corporate Officer/Principal bei STARPHARMA HOLDINGS LIMITED
Vermögen: 21 818 $ am 31.03.2024
Profil
Tony Eglezos is currently the Vice President of Business Development at Starpharma Holdings Ltd.
Prior to this, he worked as the Senior Director of Business Development and Licensing at CSL Ltd.
from 2006 to 2013.
He also held a position as Director of Commercial Operations and Pharmaceuticals at Seqirus Pty Ltd.
Dr. Eglezos holds a doctorate from the University of Melbourne and an MBA from the University of Technology Sydney.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2023 | 267 542 ( 0,06% ) | 21 818 $ | 31.03.2024 |
Aktive Positionen von Tony Eglezos
| Unternehmen | Position | Beginn |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Corporate Officer/Principal | 12.08.2013 |
Ehemalige bekannte Positionen von Tony Eglezos
| Unternehmen | Position | Ende |
|---|---|---|
| CSL LIMITED | Corporate Officer/Principal | 01.08.2013 |
Seqirus Pty Ltd.
 Seqirus Pty Ltd. BiotechnologyHealth Technology Part of CSL Ltd., Seqirus Pty Ltd. is an Australian company that develops and manufactures vaccines and plasma protein biotherapies. The private company is based in Parkville, Australia. | Corporate Officer/Principal | - |
Ausbildung von Tony Eglezos
| University of Melbourne | Doctorate Degree |
| University of Technology Sydney | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CSL LIMITED | Health Technology |
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Seqirus Pty Ltd.
Seqirus Pty Ltd. BiotechnologyHealth Technology Part of CSL Ltd., Seqirus Pty Ltd. is an Australian company that develops and manufactures vaccines and plasma protein biotherapies. The private company is based in Parkville, Australia. | Health Technology |
